v3.26.3
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Preferred shares
Ordinary shares
Additional paid-in Capital
Accumulated Deficit
Accumulated Other comprehensive loss
Total
Balance at Dec. 31, 2024   $ 23,054 $ 95,215,079 $ (88,691,657) $ (548,631) $ 5,997,845
Balance (in Shares) at Dec. 31, 2024   2,319,353        
Share-based expense   $ 566 362,964 363,530
Share-based expense (in Shares)   54,500        
Stock option expense   856,286 856,286
Net loss   (5,002,891) (5,002,891)
Foreign currency translation   163,849 163,849
Share issuance for exercise of pre- funded warrants   $ 6,982 (6,317) 665
Share issuance for exercise of pre- funded warrants (in Shares)   665,000        
Balance at Mar. 31, 2025   $ 30,602 96,428,012 (93,694,548) (384,782) 2,379,284
Balance (in Shares) at Mar. 31, 2025   3,038,853        
Balance at Dec. 31, 2024   $ 23,054 95,215,079 (88,691,657) (548,631) 5,997,845
Balance (in Shares) at Dec. 31, 2024   2,319,353        
Net loss           (11,402,070)
Balance at Sep. 30, 2025   $ 57,003 103,255,125 (100,093,727) (544,753) 2,673,648
Balance (in Shares) at Sep. 30, 2025   5,412,853        
Balance at Mar. 31, 2025   $ 30,602 96,428,012 (93,694,548) (384,782) 2,379,284
Balance (in Shares) at Mar. 31, 2025   3,038,853        
Share-based expense   $ 856 155,894 156,750
Share-based expense (in Shares)   75,000        
Stock option expense   160,187 160,187
Net loss   (3,479,833) (3,479,833)
Foreign currency translation   (140,126) (140,126)
Share issuance for exercise of pre- funded warrants   $ 6,805 (6,202) 603
Share issuance for exercise of pre- funded warrants (in Shares)   603,000        
Sale of ordinary shares and warrants and prefunded warrants   $ 3,309 3,530,180 3,533,489
Sale of ordinary shares and warrants and prefunded warrants (in Shares)   375,000        
Balance at Jun. 30, 2025   $ 41,572 $ 100,268,071 (97,174,381) (524,908) 2,610,354
Balance (in Shares) at Jun. 30, 2025   4,091,853        
Sale of ordinary shares     2,577,777
Sale of ordinary shares (in Shares)   2,577,777      
Share-based expense   $ 1,579   194,700
Share-based expense (in Shares)   135,000 193,121      
Stock option expense   $ 228,822 228,822
Net loss   (2,919,346) (2,919,346)
Foreign currency translation   (19,845) (19,845)
Share issuance for exercise of pre- funded warrants   $ 13,852   1,186
Share issuance for exercise of pre- funded warrants (in Shares)   1,186,000 (12,666)      
Balance at Sep. 30, 2025   $ 57,003 $ 103,255,125 (100,093,727) (544,753) 2,673,648
Balance (in Shares) at Sep. 30, 2025   5,412,853        
Balance at Dec. 31, 2025 $ 107,820 106,053,809 (104,902,375) (617,654) 641,600
Balance (in Shares) at Dec. 31, 2025 9,780,142        
Sale of preferred shares $ 35,604 2,964,396 3,000,000
Sale of preferred shares (in Shares) 3,000,000        
Sale of ordinary shares $ 20,314 2,067,925 2,088,239
Sale of ordinary shares (in Shares) 1,735,194        
Share-based expense $ 11,868 788,132 800,000
Share-based expense (in Shares)   1,000,000        
Stock option expense 176,531 176,531
Preferred shares payable 3,000,000 3,000,000
Net loss (5,081,982) (5,081,982)
Foreign currency translation (35,096) (35,096)
Balance at Mar. 31, 2026 $ 35,604 $ 140,002 115,050,793 (109,984,357) (652,750) 4,589,292
Balance (in Shares) at Mar. 31, 2026 3,000,000 12,515,336        
Balance at Dec. 31, 2025 $ 107,820 106,053,809 (104,902,375) (617,654) 641,600
Balance (in Shares) at Dec. 31, 2025 9,780,142        
Net loss           (21,479,903)
Balance at Sep. 30, 2026 $ 22,024 $ 1,004,145 141,507,845 (126,382,278) 16,151,736
Balance (in Shares) at Sep. 30, 2026 1,875,300 87,219,235        
Balance at Mar. 31, 2026 $ 35,604 $ 140,002 115,050,793 (109,984,357) (652,750) 4,589,292
Balance (in Shares) at Mar. 31, 2026 3,000,000 12,515,336        
Share-based expense   $ 18,775 420,784 439,559
Share-based expense (in Shares)   1,591,714        
Stock option expense (528,922) (528,922)
Net loss (11,016,480) (11,016,480)
Foreign currency translation (30,683) (30,683)
Preferred shares issued $ 23,488 (23,488)
Preferred shares issued (in Shares) 2,000,000        
Ordinary shares issued for exercise of warrants $ 102,669 15,132,372 15,235,041
Ordinary shares issued for exercise of warrants (in Shares) 8,700,854        
Ordinary shares issued for in-process research and development $ 24,617 3,233,832 3,258,449
Ordinary shares issued for in-process research and development (in Shares) 2,121,386        
Stock payable for acquisition of intellectual property 5,470,400 5,470,400
Share-based expense payable 2,263,250 2,263,250
Reclassification of translation adjustment related to liquidation of foreign subsidiary 683,433 683,433
Balance at Jun. 30, 2026 $ 59,092 $ 286,063 141,019,021 (121,000,837) 20,363,339
Balance (in Shares) at Jun. 30, 2026 5,000,000 24,929,290        
Share-based expense $ 33,125 833,459 866,584
Share-based expense (in Shares) 2,882,777        
Stock option expense 282,399 282,399
Net loss (5,381,441) (5,381,441)
Foreign currency translation (10,371) (10,371)
Share-based expense payable 20,855 20,855
Reclassification of translation adjustment related to liquidation of foreign subsidiary 10,371 10,371
Ordinary shares issued for conversion of Preferred shares $ (37,068) $ 634,923 (597,855)
Ordinary shares issued for conversion of preferred shares (in Shares) (3,124,700) 55,057,500        
Ordinary shares issued in partial settlement of stock payable for acquisition of intellectual property $ 50,034 (50,034)
Ordinary shares issued in partial settlement of stock payable for acquisition of intellectual property (in Shares) 4,349,668        
Balance at Sep. 30, 2026 $ 22,024 $ 1,004,145 $ 141,507,845 $ (126,382,278) $ 16,151,736
Balance (in Shares) at Sep. 30, 2026 1,875,300 87,219,235